ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

Lung Cancer Size May Not Indicate Severity Of Disease

March 29, 2002

DCT Board Approves Concepts For New RFA, New And Recompeting Contracts

June 18, 1982

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

July 29, 2011

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Artificial Neural Networks Predict Clinical Outcomes

November 26, 2004